Victory Capital Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,304
Closed -$191K 2546
2020
Q3
$191K Sell
10,304
-4,356
-30% -$77.3K ﹤0.01% 2296
2020
Q2
$261K Sell
14,660
-14,660
-50% -$223K ﹤0.01% 2223
2020
Q1
$270K Buy
29,320
+13,845
+89% +$207K ﹤0.01% 2262
2019
Q4
$265K Hold
15,475
﹤0.01% 2236
2019
Q3
$161K Buy
15,475
+14,815
+2,245% +$199K ﹤0.01% 2291
2019
Q2
$10K Hold
660
﹤0.01% 1809
2019
Q1
$12K Hold
660
﹤0.01% 1759
2018
Q4
$11K Sell
660
-126
-16% -$2.92K ﹤0.01% 1764
2018
Q3
$22K Buy
786
+103
+15% +$2.96K ﹤0.01% 1754
2018
Q2
$19K Hold
683
﹤0.01% 1798
2018
Q1
$22K Hold
683
﹤0.01% 1787
2017
Q4
$20K Hold
683
﹤0.01% 1786
2017
Q3
$19K Hold
683
﹤0.01% 1777
2017
Q2
$18K Buy
+683
New +$16.3K ﹤0.01% 1774

Other funds holding CLLS

Victory Capital Management's CLLS Position: Q4 2020 in Review

Victory Capital Management sold out of Cellectis (CLLS) in Q4 2020, closing a stake of 10,304 shares — an estimated $191K sold.

Victory Capital Management first reported a position in CLLS in Q2 2017 and held it in 14 quarters. The position peaked at $270K in Q1 2020. 90 funds tracked by Wall St. Rank hold CLLS as of Q4 2020.

  • Victory Capital Management reported no remaining Cellectis position as of Q4 2020 after selling out during the quarter.
  • Victory Capital Management sold 10,304 Cellectis shares in Q4 2020, an estimated $191K.
  • Victory Capital Management first reported a position in Cellectis in Q2 2017 and held it in 14 quarters.
  • Victory Capital Management's Cellectis position peaked at $270K in Q1 2020.
  • 90 funds tracked by Wall St. Rank held Cellectis as of Q4 2020.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.